Who Paid My Doc
Ascenda
Device Drug Infusion Systems
PDI 00763000051112
General payments
$369,433
Research payments
$7,156,260
Through program year 2025, $369,433 in general payments and $7,156,260 in research payments were reported against Ascenda (Drug Infusion Systems).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $65,094 | 50 |
| 2024 | General | $60,892 | 41 |
| 2024 | Research | $1,825,376 | 70 |
| 2023 | General | $84,664 | 155 |
| 2023 | Research | $1,683,324 | 78 |
| 2022 | General | $82,381 | 208 |
| 2022 | Research | $2,028,174 | 90 |
| 2021 | General | $76,402 | 150 |
| 2021 | Research | $1,619,386 | 98 |
Breakdown
The top 5 of 43 recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
604 general · 336 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.